High-Value Targets, Now Within Reach
Of the ~5,000 proteins involved in human disease, only about 600 have been successfully targeted with small molecule therapeutics. That leaves a vast proportion of the proteome unexplored and a big catalog of targets on drug developers’ wish lists.